Photo from wikipedia
Cystatin‐C (Cys‐C) is a predictor of several malignancies. However, whether Cys‐C levels predict prognosis in patients with papillary renal cell carcinoma (PRCC) remains uncertain. The aim of this study was… Click to show full abstract
Cystatin‐C (Cys‐C) is a predictor of several malignancies. However, whether Cys‐C levels predict prognosis in patients with papillary renal cell carcinoma (PRCC) remains uncertain. The aim of this study was to assess the correlation between Cys‐C and clinical outcomes in patients with PRCC.
Keywords:
association preoperative;
prognosis patients;
cystatin;
patients prcc;
study
Journal Title: Cancer Medicine
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer Medicine
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!